The University of Tokyo · 医学
フロリアノ・アミモ教授の研究室は、アフリカをはじめとする発展途上地域における感染症の予防・制御に焦点を当てた公衆衛生研究を推進しています。特に、COVID-19がHIV、結核、マラリアといったエピデミック疾患の制御に与える影響を、疫学的・制度的視点から分析しています。また、医療システムの弱体化や薬剤耐性の拡大といった構造的リスクに対処するための持続可能な政策戦略の構築にも注力しています。
Figures are computed from collected data and may differ slightly.
Despite its current relatively low global share of cases and deaths in Africa compared to other regions, coronavirus disease 2019 (COVID-19) has the potential to trigger other larger crises in the region. This is due to the vulnerability of health and economic systems, coupled with the high burden of human immunodeficiency virus (HIV), tuberculosis (TB), and malaria. Here we examine the potential implications of COVID-19 on the control of these major epidemic diseases in Africa. We use current e
Under the WHO protocols, SP is no longer effective for intermittent preventive treatment in pregnancy and infancy in most of eastern Africa and parts of central Africa. Strengthening health systems capacity to monitor drug resistance at subnational levels across the endemicity spectrum is critical to achieve the global target to end the epidemic.
Innovative and sustainable strategies informed by comparative risk assessment are increasingly needed to ensure that local economic, social, demographic, and epidemiological risks and potentials are accounted for in the national COVID-19 responses.
Ensuring that malaria vaccines deliver maximum public health impact is non-trivial. Drawing on current research, this article examines hurdles that malaria immunization may face to reach high-risk children and explores the policy implications. The analysis finds health system related risks with the potential to reduce the ability of malaria vaccines to provide equitable protection. Deployment of effective frameworks to tackle these risks so as to strengthen within-country equity and progress tra
<title>Abstract</title> <bold>Background </bold>We reviewed current evidence on the impact of COVID-19 on HIV, tuberculosis, and malaria across Africa.<bold>Methods </bold>We searched medical databases up to 15 September 2020 for epidemiological studies that investigated the impact of COVID-19 on HIV, tuberculosis, and malaria in terms of morbidity, mortality, or healthcare accessibility, covering African countries. We consulted global health and government sources for population surveys providi
Manmade disasters are compounded by fragile institutions and high propensity to natural disasters due
CRD42018095138.
These results show that CC screening programs in resource-constrained settings need approaches tailored to different segments of women with respect to education and income to achieve equitable improvement in the levels of screening uptake.
KEYWORDS: Catastrophic health spendingchildhood immunizationcombination vaccinehealth inequityhealth systemhigher-valent vaccinemedical impoverishmentvaccine introduction
Malaria vaccine introduction in endemic countries is a game-changing milestone in the fight against the disease. This article examines the inequity in the global pharmaceutical research, development, manufacturing, and trade landscape. The role of inequity in hindering progress towards malaria elimination is explored. The analysis finds that transformational changes are required to create an equity-enabling environment. Addressing the inequity is critical to maximizing the public health impact o
Dear Editor, I read with interest the article ''Acceptance and willingness to pay for DTaP-HBV-IPV-Hib hexavalent vaccine among parents: a cross-sectional survey in China'' by Huang et al. 1 The authors highlighted the importance of introducing highervalent pediatric combination vaccines into national immunization programs to improve vaccine acceptance, so as to harness their advantages over lower-valent vaccines.These advantages include requiring fewer injections, which can potentially reduce i
Open papers in the app to read, cite, and organize with AI.